Kunxian Capsule

DRUG4 trials

Sponsors

Gu Jieruo, Chinese SLE Treatment And Research Group, First Affiliated Hospital Xi'an Jiaotong University, Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine

Conditions

Ankylosing SpondylitisDiabetic NephropathyRheumatoid ArthritisRheumatoid Arthritis (RA)Treatment

Phase 4

Efficacy and Safety of Kunxian Capsule in Treatment Patients With Early Ankylosing Spondylitis

CompletedNCT00953979

Gu JieruoAnkylosing Spondylitis, Treatment

Start: 2008-01-31End: 2009-12-31Updated: 2012-01-19

Kunxian for the Treatment of Rheumatoid Arthritis

Chinese SLE Treatment And Research GroupRheumatoid Arthritis

Start: 2015-09-30End: 2017-11-30Target: 428Updated: 2017-03-09

Integrated Clinical Study of Traditional Chinese and Western Medicine for Refractory Rheumatoid Arthritis

RecruitingNCT07721142

Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western MedicineRheumatoid Arthritis (RA)

Start: 2025-10-15End: 2028-03-15Target: 300Updated: 2026-07-22

Unknown Phase

Study on the Efficacy and Safety of a Novel Tripterygium Wilfordii Preparation in Reducing Proteinuria in Patients With Diabetic Nephropathy

CompletedNCT04981613

First Affiliated Hospital Xi'an Jiaotong UniversityDiabetic Nephropathy

Start: 2021-07-28End: 2024-08-28Updated: 2025-08-12

Related Papers

Mitochondrial Oxidative Metabolism: An Emerging Therapeutic Target to Improve CKD Outcomes.

2023-05-2911 citations

Kunxian capsules in the treatment of patients with ankylosing spondylitis: a randomized placebo-controlled clinical trial

Trials2016-07-2120 citations